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Abstract 
 
Objective Progressive supranuclear palsy (PSP) is characterized neuropathologically 
by neuronal loss, gliosis, and the presence of tau-immunoreactive neuronal and glial 
cell inclusions affecting subcortical and some cortical regions. The objectives of this 
study were to determine (1) the spatial patterns of the tau-immunoreactive pathology, 
viz., neurofibrillary tangles (NFT), oligodendroglial inclusions (GI), tufted astrocytes 
(TA), and Alzheimer’s disease (AD)-type neuritic plaques (NP) in PSP and (2) to 
investigate the spatial correlations between the histological features. Patients Post-
mortem material of cortical and subcortical regions of eight PSP cases was studied. 
Spatial pattern analysis was applied to the NFT, GI, TA, NP, abnormally enlarged 
neurons (EN), surviving neurons, and glial cells. Results NFT, GI, and TA were 
distributed either at random or in regularly distributed clusters. The EN and NP were 
mainly randomly distributed. Clustering of NFT and EN was more frequent in the 
cortex and subcortical regions respectively. Variations in NFT density were not 
spatially correlated with the densities of either GI or TA but were positively correlated 
with the densities of EN and surviving neurons in some regions. Conclusion (1) NFT 
were the most widespread tau-immunoreactive pathology in PSP being distributed 
randomly in subcortical regions and in regular clusters in cortical regions, (2) GI and 
TA were more localized and exhibited a regular pattern of clustering in subcortical 
regions, and (3) neuronal and glial cell pathologies were not spatially correlated.  
 
Key Words: Progressive supranuclear palsy (PSP), Neurofibrillary tangle (NFT), 
Oligodendroglial inclusion (GI), Tufted astrocyte (TA), Spatial pattern 
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Introduction 
 
Progressive supranuclear palsy (PSP) is a mainly sporadic, multisystem 
neurodegenerative disorder first described as a clinical entity in 1964 [1]. The 
disorder has a prevalence of 6.4/100 000 of the population [2,3] and is the second 
most common syndrome in which ‘parkinsonism’ is a prominent symptom [4]. The 
first description of PSP was based on nine cases that exhibited supranuclear 
ophthalmoplegia, pseudobulbar palsy, dysarthria, and dystonic rigidity of the upper 
neck and trunk [5,6]. In addition, despite the predominantly subcortical symptoms, 
some patients also exhibit frontal lobe signs (‘dysexecutive syndrome’) suggesting a 
degree of cortical involvement [6,8].  
 
Neuropathologically, PSP may be distinguished from normal adult brains and from 
Parkinson’s disease (PD) by symmetrical tissue loss in the frontal cortex (maximal in 
the orbitofrontal and medial frontal cortices), subcortical nuclei (midbrain, caudate, 
and thalamic) [9]. In addition, there is neuronal loss, gliosis, neurofibrillary tangles 
(NFT), granulovacuolar change (GVC), and demyelination, mainly affecting the 
globus pallidus, subthalamic nucleus, substantia nigra, dentate nucleus of the 
cerebellum, and brain stem tegmentum [10,11]. The NFT are structurally and 
biochemically different to those observed in Alzheimer’s disease (AD). There are 
both globose and flame-shaped NFT composed of 15nm straight filaments comprising 
six or more protofilaments 2-5nm in diameter [12,13]. The NFT are tau-
immunoreactive and composed largely of 4-microtubule binding-repeat (4R) tau [14]. 
PSP is therefore classified among the tauopathies, a group of disorders that also 
includes AD, Pick’s disease (PiD), corticobasal degeneration (CBD), the NFT 
predominant form of senile dementia (NFT-SD), argyrophilic grain disease (AGD), 
and parkinsonism-dementia complex of Guam (Guam PDC) [15,16]. Abnormally 
enlarged neurons (EN) are present, especially in the inferior olivary nucleus [10] and 
throughout the neocortex [17]. In addition, ‘tufted’ astrocytes (TA) and glial 
inclusions (GI) (‘coiled bodies’) [18-20] are present in the motor cortex and striatum 
[14]. The presence of TA is often regarded as diagnostic for PSP [19] and 
distinguishes the disorder from the closely-related CBD [21]. Finally, neuritic plaques 
(NP), also termed ‘NFT-associated neuritic clusters’, are present in the hippocampus 
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and adjacent gyri of some cases [22] and consist of numerous degenerating axon 
terminals.  
 
In other tauopathies such as Alzheimer’s disease (AD), Pick’s disease (PiD), and 
corticobasal degeneration (CBD), the pathology exhibits a characteristic spatial 
pattern in coronal sections of brain tissue, viz., in the cortex, the inclusions occur in 
clusters that exhibit a regular distribution parallel to the pia mater [23]. This 
topographic pattern suggests that the inclusions develop in association with clusters of 
neurons associated with the cortico-cortical projections [23-25]. PSP, however, 
differs from other tauopathies in first, the pathology is predominantly subcortical and 
second, significantly affects astrocytes and oligodendrocytes as well as neurons. A 
previous study suggested that NFT may be clustered in some cortical regions in PSP 
[7,26]. Hence, to characterize the pattern of degeneration in cortical and subcortical 
regions in PSP and the relationships between the various pathological inclusions, we 
determined: (1) whether the NFT, GI, TA, and NP exhibited a similar topographic 
distribution to those previously reported in the tauopathies and (2) the spatial 
correlations between the NFT, GI, TA, and NP and between the tau-immunoreactive 
inclusions and surviving neurons, EN, and glial cells.  
 
Materials and Methods 
 
Cases  
 
Brain material from eight cases of PSP (see Table 1) was obtained from the 
Department of Neuropathology, Institute of Psychiatry, King’s College London, UK 
and were the same eight cases used to study laminar distribution of the pathology in 
PSP [8]. Patients had no family history of psychiatric or neurological disorders and 
were clinically diagnosed as ‘definite’ PSP using National Institute of Neurological 
Disorders and Stroke (NINDS) and the Society of PSP (SPSP) clinical criteria [27-
29]. Two clinical phenotypes of PSP have been identified, viz., Richardson’s 
syndrome (RS) and PSP-parkinsonism (PSP-P), the two subtypes varying in disease 
duration and in tau isoforms [30]. All cases studied were of the classical RS subtype 
of PSP. In addition, with two exceptions (Cases C and F), cases represented Braak 
tangle stages I or II [31]. The most common disease presentations were confusion 
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and/or memory problems (four patients) and early falls (three patients). Later, postural 
instability leading to frequent falls, rigidity, poor memory, and gait problems were 
more frequent. Memory problems and confusion were exhibited by the majority of 
patients. Visual problems were present in all patients, vertical supranuclear gaze palsy 
being the most consistent symptom. A diagnosis of AGD, which also has 4R-tau 
positive oligodendrocytic and astrocytic inclusions [32], can be excluded as the 
majority of patients were young, exhibited supranuclear gaze palsy, and EN were 
mainly absent in the cingulate gyrus and amygdala. A diagnosis of corticobasal 
degeneration (CBD) was excluded by the absence of astrocytic plaques, the presence 
of globose or flame shaped NFT rather than wispy-fine NFT, and lack of neuropil 
threads [14,33]. Although EN are present in PSP they are not as abundant as in other 
tauopathies such as CBD [17] and our cases conform to this distribution. In addition 
where CBD and PSP pathology occur in the same case, there is the possibility of a 
diagnosis of frontotemporal dementia with parkinsonism linked to chromosome 17 
(FTLD-17) but no MAPT mutations were present in the cases studied.  
 
Histological methods  
 
After death, the consent of the next of kin was obtained for brain removal, following 
local Ethical Committee procedures and the 1995 Declaration of Helsinki (as 
modified Tokyo, 2004). The following tissue blocks were taken from each case: (1) 
frontal lobe at the level of the genu of the corpus callosum to study the superior 
frontal cortex (SFC) (B8) and anterior cingulate gyrus (CG) (B24), (2) temporal lobe 
at the level of the lateral geniculate body (LGN) to study the inferior temporal gyrus 
(ITG) (B20), sectors CA1/2 of the hippocampus (HC), and dentate gyrus (DG), (3) 
striatum at the level of the anterior commissure to study the putamen (PT) and globus 
pallidus (GP), (4) mid-brain at the level of the third cranial nerve to study the 
substantia nigra (SN) and red nucleus (RN), (5) rostral pons through the mid-point of 
the locus caeruleus (LC) to study both the LC and pontine nuclei (PN), (6) mid-
medulla through the maximum diameter of the inferior olive to study the inferior 
olivary nucleus (ION), and (7) cerebellar hemisphere taken through the superior 
cerebellar peduncle to include the dentate nucleus. Tissue was fixed in 10% formal 
buffered saline and embedded in paraffin wax. 7µm sections were  stained with a 
variety of standard staining methods including H/E, Bielschowsky silver staining 
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method, Luxol fast blue, and glial fibrillary acidic protein (GFAP). In addition, 
sections were immunolabelled with an antibody (TP70) [28] that recognizes all forms 
of tau and is raised to the peptide corresponding to residues 428-441 at the C-terminal 
portion of the protein.  
 
Morphometric methods 
 
In cortical regions (SFC, CG, ITG), the histological features were counted along strips 
of tissue (3200 to 6400µm in length) parallel to the pia mater using 50 x 250µm 
sample fields arranged contiguously. The fields were located to study variations in 
density along the upper (laminae II/III) and lower (laminae V/VI) cortex, the short 
edge of the field (50m) being aligned with guidelines marked on the slide and 
arranged parallel to the pia mater. In the HC, the pathological changes were counted 
from the beginning of sector CA1 to the CA2/CA3 boundary, the short dimension of 
the field being aligned with the alveus. In the DG, the field was aligned with the 
upper edge of the granule cell layer. Two areas were sampled in the striatum, viz., the 
PT and the GP, the fields being located along the edges of the external and internal 
capsules respectively. In the midbrain, fields were aligned along the lower edge of the 
crus cerebri to sample the SN as far as the cortinonigral fibres and transversely across 
the maximum diameter of the RN. In the rostral pons, the fields were arranged across 
the maximum diameter of the LC and across the PN at the base of the pons. In the 
medulla, the fields followed the contours of the principal ION and were aligned with 
the central tegmental tract. In the cerebellum, the fields were located along the lower 
edge of the granule cell layer to sample the Purkinje cells. All NFT, GI, TA, NP, EN, 
surviving neurons, and glial cells were counted within each sample field. GI were 
associated with oligodendroglial cell nuclei and TA with an astrocyte cell body while 
NFT were present in the cytoplasm of larger cells with a distinct nucleus and 
cytoplasm and immunolabelled sections were compared with Bielschowsky silver 
stain to ensure that immunolabelled cells contained NFT rather than being simply tau-
immunoreactive neurons. NP were tau immunoreactive structures consisting of 
clusters of degenerating axon terminals and silver stained sections were examined to 
ensure that they were not the astrocytic plaques (AP) characteristic of CBD. EN in 
PiD, CBD, PSP, and AD may be immunolabelled with anti-phosphorylated 
neurofilament (NF) protein although EN associated with infarction are less intensely 
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labeled by this procedure [34]. In addition, alpha-B-crystallin, a heat shock protein 
that functions as a molecular chaperone under conditions of stress, is reported to be a 
sensitive marker for detecting EN in AD [35]. Nevertheless, it is unclear whether all 
EN are immunolabeled by alpha-B-crystallin. For example, after infarction, normal 
neurons become convex and develop the characteristic appearance of BN after about 
10 days but alpha-B-crystallin immunoreactivity increases only in the later stages of 
their development [36]. Small numbers of EN were observed in the PSP cases and 
hence, a morphological criterion was used to define EN as not all of these cells in PSP 
were immunoreactive to alpha B-crystallin. Hence, EN had abnormally enlarged 
perikarya, lacked NFT, had a shrunken nucleus displaced to the periphery of the cell, 
and the maximum cell diameter was at least three times the nucleus diameter. 
Surviving neurons were identified as cells containing at least some stained cytoplasm 
in combination with larger shape and non-spherical outline. Small spherical or 
asymmetrical nuclei without cytoplasm but with the presence of a thicker nuclear 
membrane and more heterogeneous chromatin were identified as glial cells. 
 
Data analysis 
 
Measuring the spatial pattern of a histological object, i.e., whether the object is 
distributed at random, regularly, or forms clusters, may provide more information 
than a simple estimate of abundance [37,38]. Hence, the spatial pattern of a 
pathological lesion such as NFT may reflect the degeneration of underlying 
neuroanatomical structures and hence, may be useful in determining lesion 
pathogenesis [37]. 
 
To determine the spatial patterns of the histological features, the data were analyzed 
by spatial pattern analysis [37,38]. This method uses the variance-mean ratio (V/M) 
of the data to determine whether the histological features were distributed randomly 
(V/M = 1), regularly (V/M < 1), or were clustered (V/M > 1) along a strip of tissue. 
Counts of a feature in adjacent sample fields were then added together successively to 
provide data for increasing field sizes, e.g., 50 x 250µm, 100 x 250µm, 200 x 250µm 
etc., up to a size limited by the length of the strip sampled. V/M was plotted against 
field size measured parallel to the pia mater to determine first, whether the clusters of 
a histological feature were regularly or randomly distributed and second, to estimate 
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the mean cluster size. A V/M peak indicated the presence of regularly spaced clusters 
while an increase in V/M to an asymptotic level suggested the presence of randomly 
distributed clusters [38]. The statistical significance of a peak was tested using the ‘t’ 
distribution [37,38]. The frequencies of the different types of spatial pattern were 
compared between cortical and subcortical regions using chi-square (2) contingency 
table tests. Spatial correlations between histological features were tested for each 
region by calculating Pearson's correlation coefficient ('r') between the densities 
measured parallel to the tissue boundary for each region [39].  
 
Results 
 
Examples of the tau-immunoreactive pathology in PSP are shown in Figs 1 and 2. 
NFT (Fig 1) were present in cells with a distinct nucleus and cytoplasm while TA (Fig 
2) consisted of tau immunoreactive processes clearly associated with an astrocyte cell 
body.  
 
Examples of the spatial patterns exhibited by the histological features in PSP are 
shown in Fig 3. The NFT (Case B, CG) exhibited a V/M peak at a field size of 400m 
suggesting the presence of regularly distributed clusters, 400m in diameter, arranged 
parallel to the pia mater. By contrast, the V/M of the EN (Case A, FC) did not differ 
significantly from unity at any field size suggesting a random distribution.  
 
The spatial patterns exhibited by all histological features in the PSP cases as a whole 
are summarized in Table 2. The NFT, GI and TA were most frequently distributed at 
random or in regularly distributed clusters. By contrast, the EN and NP were largely 
randomly distributed. The surviving neurons and glial cell nuclei exhibited a random, 
regular, or clustered distribution in different regions. Contingency table analysis (2) 
suggested that the NFT, GI, and TA were more frequently randomly distributed and 
less frequently uniformly distributed or aggregated into clusters compared with the 
surviving neurons and glial cell nuclei. The spatial patterns of some histological 
features varied in frequency in the cortex and HC compared with subcortical regions. 
Hence, NFT were more frequently clustered in the cortex and HC (2 = 7.64, P < 
0.05) while EN were more frequently clustered in subcortical regions (2 = 11.24 P < 
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0.05). Surviving neurons were more frequently distributed in clusters in the cortex 
and HC but were more frequently randomly distributed in subcortical regions (2 = 
29.10, P < 0.001). There were no significant correlations between the frequency of 
specific types of spatial pattern or cluster size with disease onset, duration or Braak 
tangle score. 
 
A summary of the spatial correlations between the densities of histological features is 
shown in Table 3. Variations in the density of NFT were not correlated with the 
densities of GI or TA. The densities of NFT, however, were positively correlated with 
the densities of surviving neurons and EN in 25% and 38% regions respectively. In 
addition, the densities of surviving neurons were positively correlated with the 
densities of EN in 39% of regions and negatively correlated with glial cell density in 
27% of regions. 
 
Discussion 
 
The first objective was to determine the spatial patterns of the tau-immunoreactive 
inclusions in PSP and compare them with those reported previously in AD [40], PiD 
[41], and CBD [42]. In approximately 60% of brain regions in PSP, the NFT were 
randomly distributed and in only 25% of regions was there evidence of clustering of 
NFT, clustering being most evident in the cortex. In addition, the GI and TA were 
distributed in regular clusters in some subcortical regions but also randomly 
distributed in many regions while the EN and NP were most frequently randomly 
distributed. By contrast, in AD [40], PiD [41], and CBD [42] neuronal inclusions 
were frequently clustered, the clusters exhibiting a regular distribution parallel to the 
tissue boundary. Hence, the spatial patterns of inclusions in PSP differ from those 
previously studied in the tauopathies, being more frequently randomly distributed and 
less frequently regularly distributed in clusters.  
 
Aging is likely to have several affects on the pathology of PSP [43] including effects 
on density and spatial patterns of inclusions. However, there were no significant 
correlations between the frequency of specific types of spatial pattern or cluster size 
with disease onset or duration. In addition, there were no significant correlations 
between spatial patterns and AD pathology as measured by Braak tangle score. AD 
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and PSP have different spatial distributions of the pathology which may explain the 
lack of correlation. However, a much larger series of cases would be required to 
specifically test the hypothesis that patient age, duration of disease, or Braak score 
influences spatial pattern in PSP. 
 
A regular distribution of clusters of NFT was most frequently observed in the cerebral 
cortex and in sectors CA1/2 of the HC. Cortical regions have a distinct anatomical 
structure, the major feature of which is the replicated local neural circuit (represented 
by ‘columns’ or ‘modules’) [44]. Various anatomical pathways connecting the cortex 
and the hippocampus also have a modular structure. The diameter of individual 
cortical modules varies between 500 and 1000m depending on region [25,41] and 
those that comprise specific cortico-cortical pathways occur in bands that are more or 
less regularly distributed along the cortex. Previous studies of the tauopathies suggest 
that inclusions in the cortex may be associated with these projections [23]. Hence, the 
random distribution of NFT in subcortical regions could be attributable to a lack of a 
distinct modular organization. Nevertheless, the EN, GCI and AP were clustered in 
some subcortical regions. In addition, projections from the cortex to the cerebellum 
are topographically organized in columns [45] while in the striatum, corticostriate 
terminals originating from a particular area of cortex also exhibit a patchy stripe-like 
distribution [45]. An alternative explanation is that the pathology of PSP may develop 
initially in subcortical areas in association with specific anatomical pathways. 
However, as the disease develops the pathology becomes more widespread and 
diffuse so that the original topographic pattern is lost. By contrast, pathology in 
cortical areas may be a later development and more likely to retain evidence of the 
original topographic pattern of inclusions [6-8].
 
 
 
The second objective was to determine the spatial relationships between the 
histological features. As in the synucleinopathy multiple system atrophy (MSA), there 
is prominent glial cell pathology in PSP and the relationship between the neuronal 
and glial cell pathologies in PSP has not been established. Glial pathology could be 
secondary to that of the neuronal pathology, be the primary pathological change, or 
occur independently but concurrently with neuronal pathology. In PSP, there were 
few spatial correlations between the densities of NFT and the GI, TA, or glial cell 
nuclei within individual regions. The NFT, however, were often more widely 
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distributed and abundant than both the GI and TA [8] suggesting that neuronal 
pathology is the primary change in PSP. Hence, the lack of spatial correlation 
observed between neuronal and glial cell pathologies in specific regions may be a 
consequence of the more widespread distribution of the NFT and the more localized 
clustering of the GI and TA.  
 
A positive spatial correlation was observed between the densities of NFT and EN in 
approximately 40% of brain regions studied. In PSP, EN are less abundant compared 
with similar cellular changes in PiD (‘Pick’ cells) [17] or CBD (‘ballooned neurons’) 
[17] but were more frequent in subcortical areas and often developed in large clusters 
in the pontine nuclei and inferior olivary nucleus [43]. There are two possible 
explanations for this correlation. First, NFT and EN could represent different stages 
of the same pathology, i.e., neuronal enlargement may precede or follow that of the 
development of NFT. Nevertheless, few EN had NFT and neurons containing NFT 
were not noticeably enlarged in our cases. Second, NFT and EN could represent 
different pathological processes occurring independently but within the same columns 
of neurons. Hence, NFT and EN could be the consequence of disruption of the 
cytoskeleton and the effect of synaptic disconnection respectively. Lack of correlation 
between NFT and EN in a significant proportion of regions could be attributable to 
the ‘stage’ of the disease, i.e., as the disease develops and pathology becomes more 
widespread, the correlation is lost. However, positive correlations between NFT and 
EN were not significantly more frequent in shorter duration cases which would argue 
against this hypothesis. 
 
Previous data suggest that several types of NCI, including those in PSP, regardless of 
morphology or molecular composition, are clustered in the cortex and, in a significant 
proportion of gyri, the clusters of NCI are regularly distributed parallel to the pia 
mater [23]. The spatial patterns of the NCI is consistent with their development in 
association with the cells of origin of specific anatomical pathways [23] and therefore 
could be the result of cell to cell transfer of pathogenic proteins  proposed by Goedert 
et al [46] and Steiner et al [47]. In addition, in many neurodegenerative disorders, the 
density of pathological inclusions varies significantly perpendicular to the pia mater 
[8]. The laminar distribution of an inclusion may reflect degeneration of neural 
pathways that have their cells of origin or axon terminals located within one or more 
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laminae and can therefore also indicate the pattern of cortical degeneration in a 
disorder. 
 
In conclusion, the cellular inclusions in PSP exhibit a different spatial pattern 
compared with other disorders with tau-immunoreactive inclusions such as AD [40], 
PiD [41], and CBD [42]. NFT were frequently randomly distributed in PSP especially 
in subcortical areas, consistent with a widespread neuronal pathology and which is not 
restricted to a specific anatomical pathway. In cortical regions, however, the NFT 
exhibit a spatial pattern similar to that observed in other tauopathies, e.g., a regular 
distribution of clusters parallel to the tissue boundary consistent with a later 
development. GI and TA remain more localized in their distribution and may retain 
their original regular pattern of clustering in subcortical areas. The data also suggest 
that there is a spatial correlation between the NFT and EN at some stages of the 
disease.  
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Table 1. Demographic features, gross fresh brain weight, and Braak stage of the eight 
progressive supranuclear palsy cases (PSP) studied. 
_____________________________________________________________________ 
Case  Sex Onset Age Atrophy BW NP Braak stage  
  (yrs) (yrs) 
_____________________________________________________________________ 
A  F 53 64 general, Fr 961 + 1 
B  M 65 70 none  1175 + 1 
C  M 66 74 Mo, Fr,P 498R 0 2 
D  M 59 66 none  1016 + 1 
E  F 69 75 Mo, Fr,P 515R + 1 
F  M 76 86 mild  1063 0 3 
G  F 75 81 none  1037 ++ 2 
H  F 67 71 slight Fr,P 562R 0 1 
_____________________________________________________________________ 
Abbreviations: M = Male, F = Female, Fr = Frontal lobe, P = Parietal lobe, Mo = 
Moderate, R = Right hemisphere, BW = Brain weight, Neuritic plaque (NP) density: 0 
= absent, + = few, ++ = moderate.  
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Table 2. Frequency of the different types of spatial pattern in cortical and subcortical 
areas in eight cases of progressive supranuclear palsy.  
____________________________________________________________________ 
Feature  Region  R Reg Regular clusters Large clusters 
____________________________________________________________________ 
NFT  Cortex/HC 11 0 9   2 
  Subcortex 29 1 5   1 
GI  Cortex/HC 4 0 5   2 
  Subcortex 18 1 12   2 
TA  Cortex/HC 3 0 0   0 
  Subcortex 4 0 7   2 
NP  Cortex/HC 4 0 0   0 
  Subcortex 0 0 0   0 
EN  Cortex/HC 23 0 3   1 
  Subcortex 10 2 2   7 
SN  Cortex/HC 12 33 5   14 
  Subcortex 33 6 7   17 
GL  Cortex/HC 23 17 9   15 
  Subcortex 14 16 6   19  
_____________________________________________________________________ 
Abbreviations: R = Random distribution, Reg = Regular distribution, NFT = 
Neurofibrillary tangles, GI = Glial inclusions, TA = Tufted astrocytes, NP = Neuritic 
plaques, EN = Enlarged neurons, SN = Surviving neurons, GL = Glial cell nuclei, HC 
= Hippocampus. 
Chi-square (2) contingency table tests: Statistically significant comparisons only: 1) 
Between different lesions totaled over all regions: NFT/SN 2 = 41.68***, NFT/GL 
2  = 38.98***, GI/EN 2  = 9.40*, GI/SN 2  = 29.85***, GI/GL 2  = 25.05***, 
TA/EN 2  = 12.43**, TA/SN 2 = 19.15***, TA/GL 2 = 14.57**, EN/SN 2 = 
31.01***, EN/GL 2  = 31.45***; 2) Comparison of individual lesions between 
cortex/HC and subcortical regions; NFT 2 = 7.64 (3DF, P < 0.05), EN 2 = 11.24 
(3DF, P < 0.05); SN 2  = 29.10 (3DF, P < 0.001). All other comparisons were not 
statistically significant. 
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Table 3. Frequency of the spatial correlations (Pearson’s ‘r’) between lesions, in 
cortical and subcortical areas in progressive supranuclear palsy (PSP). 
 
     Frequency of correlation 
_____________________________________________________________________ 
Variables correlated N Positive ‘r’  Negative ‘r’  NS 
_____________________________________________________________________ 
NFT/GI  49 4   2   43 
NFT/TA  16 1   0   15 
NFT/EN  38 15   0   23 
NFT/SN  68 17   0   51 
NFT/GL  71 5   7   59 
GI/TA   18 0   0   18 
GI/EN   31 2   0   29 
GI/SN   59 0   6   53 
GI/GL   58 5   0   53 
TA/EN  9 4   0   5 
TA/SN   20 1   0   19 
TA/GL  20 1   2   17 
EN/SN   61 24   1   36 
EN/GL  60 4   3   53 
SN/GL   119 0   33   86 
_____________________________________________________________________ 
Abbreviations: NFT = Neurofibrillary tangles, GI = Glial inclusions, TA = Tufted 
astrocytes, EN = Enlarged neurons, SN = Surviving neurons, GL = Glial cell nuclei, 
N = total number of brain regions analyzed, NS = no significant correlation.  Neuritic 
plaques were present in too few regions and at too low a density to test spatial 
correlations. 
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Legends to figures 
 
Fig 1. Neurofibrillary tangles (NFT) (arrow) in the midbrain of a case of progressive 
supranuclear palsy (PSP) (tau immunohistochemistry, haematoxylin, bar = 10m) 
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Fig 2. ‘Tufted’ astrocytes (TA) (arrow) in the putamen of a case of progressive 
supranuclear palsy (PSP) (tau immunohistochemistry, haematoxylin, bar = 10m). 
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Fig 3. Examples of the spatial patterns exhibited by the neurofibrillary tangles (NFT), 
and enlarged neurons (EN) in the cerebral cortex in a case of progressive supranuclear 
palsy (PSP) (* significant V/M peak). 
 
 
